| Biotechnology Industry | Healthcare Sector | Mr. Hai Zhang CEO | SSE Exchange | CNE1000040B4 ISIN |
| CN Country | 2,282 Employees | 30 Jun 2026 Last Dividend | - Last Split | - IPO Date |
GuiZhou SanLi Pharmaceutical Co., LTD., founded in 1995, is a prominent player in the pharmaceutical industry based in Anshun, China. The company specializes in the research and development, production, and marketing of a wide array of pharmaceutical products. Over the years, SanLi Pharmaceutical has established itself as a key supplier of various types of medications targeting different ailments and health conditions, catering to the needs of diverse patient groups. Its commitment to innovation and quality has helped it to carve a niche in the competitive pharmaceutical landscape of China.
Pediatric Medication: SanLi Pharmaceutical offers a comprehensive range of medications specially formulated for infants and children. These medications cater to the unique needs of this age group, ensuring safety and efficacy in treatment.
Respiratory System Medication: The company produces medicines aimed at treating and managing conditions affecting the respiratory system. This encompasses drugs for common ailments like asthma, bronchitis, and other respiratory disorders, providing relief and promoting better breathing.
Cardiovascular Drugs: Addressing the global challenge of cardiovascular diseases, SanLi provides a variety of drugs to combat conditions like hypertension, heart failure, and arrhythmias. Their cardiovascular range is designed to improve heart health and patient outcomes.
Injury by Fall Medication: Specializing in post-trauma care, SanLi Pharmaceutical formulates medications to support recovery from injuries caused by falls. This includes pain relievers, anti-inflammatory drugs, and compounds to accelerate healing processes.
Rehabilitation Medicine: The company also extends its portfolio to include rehabilitation medicines, aimed at helping patients regain mobility and improve their quality of life following physical impairments or surgeries.
GI Medicine: Understanding the prevalence of gastrointestinal disorders, SanLi Pharmaceuticals offers a variety of medications targeting issues like acid reflux, ulcers, and irritable bowel syndrome (IBS), among others, to improve digestive health.
Ophthalmic Medicine: Having recognized the importance of eye health, the company provides treatments for various ophthalmic conditions, including infections, glaucoma, and dry eye, ensuring comprehensive care for visual health.